ExPAEDition 2026 is a short observership exchange programme by EAP and Young EAP, offering up to five paediatric residents the opportunity to complete a clinical observership at Hospices Civils de Lyon, France, from 19–27 October 2026, followed by participation in CEPAS 2026, the joint biennial meeting of EAP and ESPR, from 28–31 October 2026.
We kindly ask National Societies to let us know whether they would be willing to:
The estimated support per participant is €1,000, proposed to be shared equally between EAP and the National Society, with each contributing €500. This support would help cover travel, accommodation, local transport, and related expenses.
This is a practical and meaningful way for National Societies to invest in the next generation of paediatricians and strengthen European professional exchange.
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.
